MAXEPA - MAXEPA - CT 1039 - English version

Has

Description

Introduction MAXEPA 1g, capsule Box of 60 (CIP: 329 763-8) Posted on Feb 15 2010 Active substance (DCI) Natural fish oil containing at least 30% omega-3 polyunsaturated fatty acids, including 18% eicosapentaenoic acid (EPA) and 12% docosahexaenoic acid (DHA), alpha-tocopherol acetate. ATC Code C10AX06 Laboratory / Manufacturer PIERRE FABRE MEDICAMENT MAXEPA 1g, capsule Box of 60 (CIP: 329 763-8) Posted on Feb 15 2010

Sujets

• Médecine

Informations

• Publié par: haute-autorite-sante-traitement-medicamenteux
• Publié le: 05 décembre 2007
• Nombre de lectures: 13
• Licence : En savoir +
  Paternité, pas d'utilisation commerciale, partage des conditions initiales à l'identique
• Langue: English

Extrait

       

 

The legally binding text is the original French version

  TRANSPARENCY COMMITTEE   OPINION    December 5, 2007         MAXEPA 1g, capsule Box of 60 (CIP: 329 763-8)   Applicant: PIERRE FABRE MEDICAMENT     Natural fish oil containing at least 30% omega-3 polyunsaturated fatty acids, including 18% eicosapentaenoic acid (EPA) and 12% docosahexaenoic acid (DHA), alpha-tocopherol acetate.     Date of initial Marketing Authorisation: July 17, 1987, July 5, 2007 (latest revision of Marketing Authorisation)       Reason for request: Inclusion on the list of medicines reimbursed by National Insurance and approved for hospital use.     The laboratory is requesting MAXEPA’s inclusion only for the management of HIV- infected patients receiving antiretroviral polytherapy and with hypertriglyceridaemia.                           Health Technology Assessment Division

 

 

1